SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.

Never miss a new study

Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS trials appear

Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with severe arthritis: testing a promising pill

Disease control Recruiting now

This study is testing a medication called baricitinib to see if it can safely control the symptoms of a severe form of childhood arthritis called systemic JIA. Children aged 1 to 18 with active arthritis will take either baricitinib or a standard treatment (tocilizumab) to compar…

Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS trials appear

New hope for kids with severe arthritis: testing a promising pill